0000950170-23-035163.txt : 20230727
0000950170-23-035163.hdr.sgml : 20230727
20230727161637
ACCESSION NUMBER: 0000950170-23-035163
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230725
FILED AS OF DATE: 20230727
DATE AS OF CHANGE: 20230727
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Loose Christopher R.
CENTRAL INDEX KEY: 0001785299
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39062
FILM NUMBER: 231118620
MAIL ADDRESS:
STREET 1: C/O FREQUENCY THERAPEUTICS, INC.
STREET 2: 19 PRESIDENTIAL WAY, 2ND FLOOR
CITY: WOBURN
STATE: MA
ZIP: 01801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Frequency Therapeutics, Inc.
CENTRAL INDEX KEY: 0001703647
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472324450
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 HAYDEN AVENUE
STREET 2: SUITE 300
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-315-4600
MAIL ADDRESS:
STREET 1: 75 HAYDEN AVENUE
STREET 2: SUITE 300
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
ownership.xml
4
X0508
4
2023-07-25
0001703647
Frequency Therapeutics, Inc.
FREQ
0001785299
Loose Christopher R.
C/O FREQUENCY THERAPEUTICS, INC.
75 HAYDEN AVE, SUITE 300
LEXINGTON
MA
02421
false
true
false
false
Chief Scientific Officer
true
Common Stock
2023-07-25
4
S
false
1390
0.50
D
187696
D
Common Stock
2023-07-26
4
S
false
1329
0.51
D
186367
D
Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.491 to $0.513. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.511 to $0.515. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
/s/ James P. Abely, Attorney-in-Fact for Christopher R. Loose
2023-07-27